Although recent vaccine approvals have raised hopes of a turnaround in the pandemic later this year, renewed waves and new variants of the virus pose concerns for the outlook. Amid exceptional ...

Then €69 per month. Complete digital access to quality FT journalism on any device. Cancel or change your plan anytime during your trial.